Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

469

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Depressive Disorder, Major
Interventions
DRUG

Vortioxetine

Encapsulated vortioxetine immediate release tablets

DRUG

Placebo

Vortioxetine placebo-matching capsules

Trial Locations (61)

Unknown

Little Rock

Carson

Cerritos

El Centro

Fresno

Glendale

Los Angeles

Oakland

Oceanside

San Diego

Santa Ana

Sherman Oaks

Stanford

Upland

Denver

Hartford

Hockessin

Fort Walton Beach

Kissimmee

Miami

Pompano Beach

Atlanta

Hoffman Estates

Naperville

Oak Brook

Indianapolis

Lafayette

Newburgh

Prarie Ridge

Wichita

Baltimore

Fall River

Watertown

Clinton Township

St Louis

Las Vegas

Nashua

Albuquerque

Staten Island

Avon Lake

Beachwood

Canton

Garfield Heights

Toledo

Oklahoma City

Salem

Allentown

Philadelphia

Pittsburgh

Lincoln

Columbia

Franklin

Dallas

DeSoto

Houston

Lake Jackson

San Antonio

The Woodlands

Salt Lake City

Roanoke

Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY